{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:10:19Z","timestamp":1756181419619,"version":"3.44.0"},"reference-count":31,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood & Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1002\/pbc.31897","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:11:27Z","timestamp":1752815487000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Daratumumab as a Toxicity\u2010Sparing Agent During Frontline Treatment of T\u2010Cell Acute Lymphoblastic Leukemia"],"prefix":"10.1002","volume":"72","author":[{"given":"Meghan","family":"Shekar","sequence":"first","affiliation":[{"name":"Texas Children's Cancer and Hematology Center  Houston Texas USA"},{"name":"Department of Pediatrics Baylor College of Medicine  Houston Texas USA"},{"name":"Department of Pediatric Oncology Dana\u2010Farber Cancer Institute  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Scientist Training Program Baylor College of Medicine  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Paek","sequence":"additional","affiliation":[{"name":"Texas Children's Cancer and Hematology Center  Houston Texas USA"},{"name":"Department of Pediatrics Baylor College of Medicine  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Schafer","sequence":"additional","affiliation":[{"name":"Texas Children's Cancer and Hematology Center  Houston Texas USA"},{"name":"Department of Pediatrics Baylor College of Medicine  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon E.","family":"Conneely","sequence":"additional","affiliation":[{"name":"Texas Children's Cancer and Hematology Center  Houston Texas USA"},{"name":"Department of Pediatrics Baylor College of Medicine  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"e_1_2_1_4_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001557"},{"key":"e_1_2_1_4_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.10008"},{"key":"e_1_2_1_4_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10091926"},{"key":"e_1_2_1_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14082021"},{"key":"e_1_2_1_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00863-5"},{"key":"e_1_2_1_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010024\u201007807\u20100"},{"key":"e_1_2_1_4_8_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283818"},{"key":"e_1_2_1_4_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042150"},{"key":"e_1_2_1_4_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163556"},{"key":"e_1_2_1_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12389"},{"key":"e_1_2_1_4_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12716"},{"key":"e_1_2_1_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14310"},{"key":"e_1_2_1_4_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1228481"},{"key":"e_1_2_1_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16154"},{"key":"e_1_2_1_4_16_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279851"},{"key":"e_1_2_1_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010019\u20100548\u2010z"},{"key":"e_1_2_1_4_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158600"},{"key":"e_1_2_1_4_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024493"},{"key":"e_1_2_1_4_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.10001"},{"key":"e_1_2_1_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201007\u2010794214"},{"key":"e_1_2_1_4_22_1","unstructured":"Children's Oncology Group.A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BMF (ABFM) Backbone in Newly Diagnosed T\u2010Lymphoblastic Leukemia (T\u2010ALL) and T\u2010Lymphoblastic Lymphoma (T\u2010LLy): A Children's Oncology Group Study. ClinicalTrials.gov Identifier: NCT02112916. Updated May 29 2019."},{"key":"e_1_2_1_4_23_1","unstructured":"Children's Oncology Group.Intensified Methotrexate Nelarabine (Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults iwth Newly Diagnosed T\u2010cell Acute Lymphoblastic Leukemia (ALL) or T\u2010cell Lymphoblastic Lymphoma: A Children's Oncology Group Study. ClinicalTrials.gov Identifier: NCT00408005. Updated March 24 2016."},{"key":"e_1_2_1_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3301"},{"key":"e_1_2_1_4_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609783"},{"key":"e_1_2_1_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_2_1_4_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00642"},{"key":"e_1_2_1_4_28_1","unstructured":"Children's Oncology Group. A Phase II Trial of Tisagenlecleucel in First\u2010line High\u2010risk (HR) Pediatric and Young Adult Patients with B\u2010cell Acute Lymphoblastic Leukemia (B\u2010ALL) who are Minimal Residual Disease (MRD) Positive at the End of Consolidation (EOC) Therapy: A Children's Oncology Group Study. ClinicalTrials.gov Identifier: NCT03876769. Updated July 26 2024."},{"key":"e_1_2_1_4_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312948"},{"key":"e_1_2_1_4_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2411680"},{"key":"e_1_2_1_4_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02200"},{"key":"e_1_2_1_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28829"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T03:47:50Z","timestamp":1756180070000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.31897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1002\/pbc.31897"],"URL":"https:\/\/doi.org\/10.1002\/pbc.31897","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"type":"print","value":"1545-5009"},{"type":"electronic","value":"1545-5017"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"2024-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e31897"}}